DSLD label record for Basis capsules by Elysium
The DSLD record lists Basis, an Elysium capsule product, with declared nicotinamide riboside 250 mg and pterostilbene 50 mg per labelled serving. It is a label snapshot, not proof of efficacy, safety or approval. [1]
Automatic summary · not editorially reviewed
FROM THE ORIGINAL LABEL
A closer look at the product
- Pack contents
- 60 Capsule(s)
- Label serving
- 2 Vegetarian Capsule(s)
- Servings per container
- 30
Ingredients & declared amounts2
Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.
| Ingredient | Amount | Per label serving |
|---|---|---|
| Nicotinamide Riboside | 250 mg | 2 Vegetarian Capsule(s) |
| Pterostilbene | 50 mg | 2 Vegetarian Capsule(s) |
Other ingredients: Microcrystalline Cellulose, Hypromellose, Vegetable Magnesium Stearate, Silica
Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.
The key findings
DSLD record 270933 lists Basis, brand Elysium, as a capsule in the category "Other Combinations". [1]
The label declares nicotinamide riboside 250 mg and pterostilbene 50 mg per labelled serving. [1]
DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]
The source at a glance
- Brand
- Elysium
- Form
- Capsule
- Pack contents
- 60 Capsule(s)
- Label serving
- 2 Vegetarian Capsule(s)
- Ingredients listed
- Nicotinamide Riboside · Pterostilbene
- Record type / format
- Dietary supplement label/database record
- Scope / context
- The described product: Basis capsules by Elysium, as listed in DSLD record 270933.
- Summary based on
- Product label / database record
Basis capsule record in the DSLD
This entry comes from the NIH Dietary Supplement Label Database (DSLD), record 270933. The label name is Basis and the declared brand is Elysium. The physical form on the label is capsule, and the DSLD product category is "Other Combinations". The record notes the label entered the database on 2022-07-21, which is not a product launch date.
Supporting source [1]
Declared ingredients per labelled serving
The record lists two declared ingredients with amounts: nicotinamide riboside at 250 mg per labelled serving and pterostilbene at 50 mg per labelled serving. These are label facts as entered in the database. The record supplies no independent product testing, no price and no batch certificate.
Supporting source [1]
What this label snapshot does not show
The record describes label declarations only. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The listed amounts are label facts, not personal dosing advice.
Supporting source [1]
How to interpret this
Product label record; not evidence of efficacy or approval. The record describes label declarations only, with no independent testing, price or batch certificate.
Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.
Source & supporting passages
Elysium · dsld.od.nih.gov
